You have 9 free searches left this month | for more free features.

Folfirinox

Showing 1 - 25 of 321

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Ductal Adenocarcinoma Trial (OT-101, FOLFIRINOX)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • (no location specified)
Oct 5, 2023

Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Oligometastatic Disease
  • FOLFIRINOX chemotherapy
  • Baltimore, Maryland
    Johns Hopkins Hospital
Nov 2, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Ann Arbor, Michigan
    Rogel Cancer Center
Jun 26, 2023

Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • FOLFIRINOX treatment
  • (no location specified)
Aug 9, 2023

Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Seoul (Bevacizumab + modified FOLFIRINOX)

Recruiting
  • Mucinous Ovarian Cancer
  • +2 more
  • Bevacizumab + modified FOLFIRINOX
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Dec 25, 2022

Locally Advanced Pancreatic Cancer Trial (FOLFIRINOX chemo, OncoSil™)

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • FOLFIRINOX chemotherapy
  • OncoSil™
  • (no location specified)
Jul 18, 2022

Resectable Pancreatic Cancer Trial in Tianjin (AG Followed by FOLFIRINOX)

Recruiting
  • Resectable Pancreatic Cancer
  • AG Followed by FOLFIRINOX
  • Tianjin, Tianjin, China
    Rui Liu
Jan 8, 2023

Pancreatic Ductal Adenocarcinoma Trial in Houston (Pembrolizumab, Folfirinox)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Houston, Texas
  • +1 more
Dec 15, 2022

Metastatic Colorectal Cancer Trial in France (Folfirinox + regorrafenib)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Folfirinox + regorrafenib
  • Nice, Alpes-Maritimes, France
  • +3 more
Jan 16, 2023

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • FOLFIRINOX
  • +9 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (Eryaspase,

Active, not recruiting
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Eryaspase
  • FOLFIRINOX
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Aug 3, 2022

Rectal Cancer, Locally Advanced Trial in Tunis (Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan),

Active, not recruiting
  • Rectal Cancer
  • Locally Advanced
  • Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
  • Radiotherapy
  • Tunis, Tunisia
    Amel Mezlini
May 19, 2023

C04.588.274.476.411.307 Trial (CPI-613, modified FFX, Bevacizumab)

Not yet recruiting
  • C04.588.274.476.411.307
  • (no location specified)
Nov 10, 2022

Pancreatic Cancer Trial (Chemotherapy, Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • (no location specified)
May 30, 2022

GastroEsophageal Cancer Trial in Boston (Irinotecan, Oxaliplatin, Leucovorin)

Active, not recruiting
  • GastroEsophageal Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 7, 2022

Metastatic Pancreatic Cancer Trial in Montpellier (GABRINOX, FOLFIRINOX)

Recruiting
  • Metastatic Pancreatic Cancer
  • GABRINOX
  • FOLFIRINOX
  • Montpellier, Hérault, France
    Institut régional du Cancer de Montpellier
Jan 2, 2022

Metastatic Pancreatic Cancer Trial in Philadelphia (FOLFIRINOX)

Recruiting
  • Metastatic Pancreatic Cancer
  • FOLFIRINOX
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Sep 26, 2022

Pancreatic Cancer Trial (Rintatolimod)

Not yet recruiting
  • Pancreatic Cancer
  • (no location specified)
Aug 8, 2022

Pancreatic Cancer Trial in Cleveland (CPI 613, Oxaliplatin, Irinotecan)

Active, not recruiting
  • Pancreatic Cancer
  • CPI 613
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 14, 2022

Pancreatic Cancer Trial in United States (drug, radiation, procedure)

Active, not recruiting
  • Pancreatic Cancer
  • FOLFIRINOX
  • +4 more
  • Aurora, Colorado
  • +9 more
Sep 7, 2022

Pancreatic Ductal Adenocarcinoma Trial (JPI-547, modified FOLFIRINOX, Gemcitabine-nab-paclitaxel)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • (no location specified)
Feb 16, 2022

Metastatic Colorectal Cancer Trial in France (Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, Panitumumab, oxaliplatin,

Recruiting
  • Metastatic Colorectal Cancer
  • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil
  • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, irinotecan
  • Avignon, France
  • +5 more
Aug 2, 2022

Pancreatic Cancer Non-resectable, Chemo Effect, Ultrasound Therapy Trial in Seoul (ALPIUS 900, an ultrasound-guided high

Recruiting
  • Pancreatic Cancer Non-resectable
  • +2 more
  • ALPIUS 900, an ultrasound-guided high intensity focused ultrasound system
  • FOLFIRINOX regimen
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Feb 20, 2022

Colorectal Cancer Stage IV Trial in Sao Paulo (mFOLFIRINOX)

Recruiting
  • Colorectal Cancer Stage IV
  • Sao Paulo, SP, Brazil
    ICESP
Apr 28, 2022

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Cholesterol metabolism disruption
  • Quebec city, Quebec, Canada
    CHU de Québec-Université Laval
Oct 17, 2022